Clinical Trial Update: Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera [Phase 2]

View source ↗

Summary

This update reports on the efficacy and safety outcomes of pegylated interferon alfa in polycythemia vera from a Phase 2 trial that has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polycythemia Vera

Drugs mentioned

• Pegylated interferon alfa (pegylated interferon alfa)

Snippet

Sponsor: PV-Nord | Conditions: Polycythemia Vera | Phase 2 | Status: COMPLETED